Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PAAS vs GSK✓SelectedUSD · GSKPAAS vs GSK performance historyLatest closeAs of+0.22%11/17
Stock and ETF performance explorer

PAAS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+153.6%
GSK return
+104.0%
Excess return
+49.7%
Maximum drawdown
-66.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-2.3%+2.5%+1.0%
7D-10.2%-3.0%-7.1%-9.2%
30D-18.9%+0.4%-19.3%-19.1%
3M-25.3%-1.2%-24.1%-25.2%
6M-36.0%+0.9%-37.0%-36.7%
YTD-30.2%+4.0%-34.2%-31.9%
1Y-3.3%+7.3%-10.5%-6.9%
3Y+160.6%+57.1%+103.5%+107.0%
5Y+41.6%+43.0%-1.3%+16.0%
10Y+153.6%+103.1%+50.6%+73.1%
All+153.6%+104.0%+49.7%+73.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling